163 related articles for article (PubMed ID: 37033105)
1. Comprehensive analysis of the expression, prognostic value and biological importance of OVO‑like proteins in clear cell renal cell carcinoma.
Lin J; Jiang M; Chen R; Zheng P; Chen G
Oncol Lett; 2023 May; 25(5):179. PubMed ID: 37033105
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of OVOLs in Breast Cancer.
Chen J; Tang H; Li T; Jiang K; Zhong H; Wu Y; He J; Li D; Li M; Cai X
Int J Gen Med; 2021; 14():3951-3960. PubMed ID: 34345183
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
Meng W; Chen B; Jiang Z; Cai B; Ma L; Guan Y
Transl Cancer Res; 2023 Aug; 12(8):2071-2098. PubMed ID: 37701098
[TBL] [Abstract][Full Text] [Related]
4. The value of EYA1/3/4 in clear cell renal cell carcinoma: a study from multiple databases.
Liu T; Nie J; Zhang X; Deng X; Fu B
Sci Rep; 2023 May; 13(1):7442. PubMed ID: 37156847
[TBL] [Abstract][Full Text] [Related]
5. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
Xie W; Xi P; Liu Y; Zhang Z; Sun T
Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
[No Abstract] [Full Text] [Related]
7. GSDMB: A novel, independent prognostic marker and potential new therapeutic target in clear cell renal cell carcinoma.
Huang H; Chen R; Deng X; Wang J; Chen J
Oncol Lett; 2024 Feb; 27(2):85. PubMed ID: 38249806
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of ETS1 expression and its prognostic value in clear cell renal cell carcinoma.
Mo M; Zhu Q; Yang L; Deng Y; Yu Y; Zhou Z
Am J Transl Res; 2024; 16(4):1062-1080. PubMed ID: 38715839
[TBL] [Abstract][Full Text] [Related]
9.
Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
[TBL] [Abstract][Full Text] [Related]
10. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
[TBL] [Abstract][Full Text] [Related]
11. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Expression and Clinical Significance of E2F Family in Clear Cell Renal Cell Carcinoma.
Chen R; Zhang Z; Hu B; Jiang M; Zheng P; Deng W; Fu B; Sun T
Int J Gen Med; 2022; 15():1193-1212. PubMed ID: 35153510
[TBL] [Abstract][Full Text] [Related]
13. Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining.
Xu Z; Wang Y; Xu J; Ang X; Ge N; Xu M; Pei C
Heliyon; 2023 Feb; 9(2):e13543. PubMed ID: 36846683
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma.
Miao S; Song J; Liu Q; Lai J; Wang H; Ran L
Med Oncol; 2022 Jun; 39(9):128. PubMed ID: 35716215
[TBL] [Abstract][Full Text] [Related]
15. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
[TBL] [Abstract][Full Text] [Related]
16. Validation of prognostic signature and exploring the immune-related mechanisms for
Chen D; Yin Z; Chen Y; Bai Y; You B; Sun Y; Wu Y
Transl Cancer Res; 2023 Oct; 12(10):2518-2532. PubMed ID: 37969386
[TBL] [Abstract][Full Text] [Related]
17. FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma.
Gou H; Chen P; Wu W
Biochem Biophys Rep; 2023 Sep; 35():101506. PubMed ID: 37457361
[TBL] [Abstract][Full Text] [Related]
18. Cuproptosis-related gene
Wang T; Liu Y; Li Q; Luo Y; Liu D; Li B
Front Immunol; 2022; 13():999823. PubMed ID: 36225932
[TBL] [Abstract][Full Text] [Related]
19. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
20. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
